(8-018) An Open-Label, Phase I, Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fexofenadine Topical Lotion 1% in Normal Healthy Volunteers
Tuesday, December 10, 2024
2:00 PM – 3:30 PM
Location: Hall G, Lower Level
Category: Evaluative Study Topic: Clinical Topics/Therapeutics
Co-Author(s): Brianna Potestio, Dominick De Wolf, Korawin Triyasakorn, Ashley Forest
